BioCentury
ARTICLE | Clinical News

Fluzone Quadrivalent: Phase III data

May 14, 2012 7:00 AM UTC

A blinded Phase III trial in >4,300 children ages 6 months to 8 years showed that antibody responses to intramuscular Fluzone Quadrivalent inactivated vaccine were non-inferior to both control vaccine...